Canixin L
Canixin L
Authorised
- Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Product identification
Medicine name:
Canixin L
Active substance:
- Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serovar Canicola, strain 601903, Inactivated1.00/Hamster protective Dose 80%1.00millilitre(s)
-
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated1.00/Hamster protective Dose 80%1.00millilitre(s)
Pharmaceutical form:
-
Liquid
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 859/92/06/0366
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet